Ashurst has advised Biotest AG; Osborne Clarke has acted for Grifols S.A. Biotest AG has entered into a delisting agreement with GRIFOLS, S.A., as part of…
Biotest Delisting from Frankfurt Stock Exchange Following Grifols’ Public Tender Offer


Ashurst has advised Biotest AG; Osborne Clarke has acted for Grifols S.A. Biotest AG has entered into a delisting agreement with GRIFOLS, S.A., as part of…
…